Reporting of Noninferiority and Equivalence Randomized Trials, JAMA, vol.295, issue.10, pp.1152-1160, 2006. ,
DOI : 10.1001/jama.295.10.1152
Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 1: Ethical and Scientific Issues, Annals of Internal Medicine, vol.133, issue.6, pp.455-463, 2000. ,
DOI : 10.7326/0003-4819-133-6-200009190-00014
Scientific and Ethical Issues in Equivalence Trials, JAMA, vol.285, issue.9, pp.1206-1208, 2001. ,
DOI : 10.1001/jama.285.9.1206
Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults, New England Journal of Medicine, vol.341, issue.25 ,
DOI : 10.1056/NEJM199912163412501
Lopinavir???Ritonavir versus Nelfinavir for the Initial Treatment of HIV Infection, New England Journal of Medicine, vol.346, issue.26, pp.2039-2046, 2002. ,
DOI : 10.1056/NEJMoa012354
Methodological standards for assessing therapeutic equivalence, Journal of Clinical Epidemiology, vol.44, issue.8, pp.839-849, 1991. ,
DOI : 10.1016/0895-4356(91)90139-Z
Trials to assess equivalence: the importance of rigorous methods, BMJ, vol.313, issue.7048, pp.36-39, 1996. ,
DOI : 10.1136/bmj.313.7048.36
Active-control equivalence trials and antihypertensive agents, The American Journal of Medicine, vol.111, issue.7, pp.553-558, 2001. ,
DOI : 10.1016/S0002-9343(01)00900-7
Abacavir-Lamivudine-Zidovudine vs Indinavir-Lamivudine-Zidovudine in Antiretroviral-Naive HIV-Infected Adults<SUBTITLE>A Randomized Equivalence Trial</SUBTITLE>, JAMA, vol.285, issue.9, pp.1155-1163, 2001. ,
DOI : 10.1001/jama.285.9.1155
Substitution of Nevirapine, Efavirenz, or Abacavir for Protease Inhibitors in Patients with Human Immunodeficiency Virus Infection, New England Journal of Medicine, vol.349, issue.11, pp.1036-1046, 2003. ,
DOI : 10.1056/NEJMoa021589
Continued indinavir versus switching to indinavir/ritonavir in HIV-infected patients with suppressed viral load, AIDS, vol.17, issue.6, pp.831-840, 2003. ,
DOI : 10.1097/00002030-200304110-00008
Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study, The Lancet, vol.363, issue.9417, pp.1253-1263, 2004. ,
DOI : 10.1016/S0140-6736(04)15997-7
Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive Patients<SUBTITLE>A 3-Year Randomized Trial</SUBTITLE>, JAMA, vol.292, issue.2, pp.191-201, 2004. ,
DOI : 10.1001/jama.292.2.191
SOLO, AIDS, vol.18, issue.11, pp.1529-1537, 2004. ,
DOI : 10.1097/01.aids.0000131332.30548.92
A randomized study of emtricitabine and lamivudine in stably suppressed patients with HIV, AIDS, vol.18, issue.17, pp.2269-2276, 2004. ,
DOI : 10.1097/00002030-200411190-00007
Once-Daily versus Twice-Daily Lamivudine, in Combination with Zidovudine and Efavirenz, for the Treatment of Antiretroviral-Naive Adults with HIV Infection: A Randomized Equivalence Trial, Clinical Infectious Diseases, vol.39, issue.3, pp.411-418, 2004. ,
DOI : 10.1086/422143
Simplification Therapy with Once???Daily Emtricitabine, Didanosine, and Efavirenz in HIV???1???Infected Adults with Viral Suppression Receiving a Protease Inhibitor???Based Regimen: A Randomized Trial, The Journal of Infectious Diseases, vol.191, issue.6, pp.830-839, 2005. ,
DOI : 10.1086/428091
Abacavir versus Zidovudine Combined with Lamivudine and Efavirenz, for the Treatment of Antiretroviral???Naive HIV???Infected Adults, Clinical Infectious Diseases, vol.39, issue.7, pp.1038-1046, 2004. ,
DOI : 10.1086/424009
Comparison of Once-Daily Atazanavir With Efavirenz, Each in Combination With Fixed-Dose Zidovudine and Lamivudine, As Initial Therapy for Patients Infected With HIV, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.36, issue.5, pp.1011-1019, 2004. ,
DOI : 10.1097/00126334-200408150-00003
Induction With Abacavir/Lamivudine/Zidovudine Plus Efavirenz for 48 Weeks Followed by 48-Week Maintenance With Abacavir/Lamivudine/Zidovudine Alone in Antiretroviral-Naive HIV-1-Infected Patients, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.39, issue.3, pp.257-264, 2005. ,
DOI : 10.1097/01.qai.0000169664.15536.20
Abacavir and Lamivudine Fixed-Dose Combination Tablet Once Daily Compared With Abacavir and Lamivudine Twice Daily in HIV-Infected Patients Over 48 Weeks (ESS30008, SEAL), JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.40, issue.4, pp.422-427, 2005. ,
DOI : 10.1097/01.qai.0000184859.24071.bd
Atazanavir plus ritonavir or saquinavir, and lopinavir/ritonavir in patients experiencing multiple virological failures, AIDS, vol.19, issue.7, pp.685-694, 2005. ,
DOI : 10.1097/01.aids.0000166091.39317.99
Abacavir Once or Twice Daily Combined With Once-Daily Lamivudine and Efavirenz for the Treatment of Antiretroviral-Naive HIV-Infected Adults, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.38, issue.4, pp.417-425, 2005. ,
DOI : 10.1097/01.qai.0000147521.34369.c9
Antiretroviral treatment simplification with 3 ,
Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV, Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV, pp.251-260, 2006. ,
DOI : 10.1056/NEJMoa051871
Quality of Reporting of Noninferiority and Equivalence Randomized Trials, JAMA, vol.295, issue.10, pp.1147-1151, 2006. ,
DOI : 10.1001/jama.295.10.1147
Significance Testing to Establish Equivalence between Treatments, with Special Reference to Data in the Form of 2 x 2 Tables, Biometrics, vol.33, issue.4, pp.593-602, 1977. ,
DOI : 10.2307/2529457
An alternative to the use of two-sided tests in clinical trials, pp.1729-1738, 1996. ,
Noninferiority trials, Current Controlled Trials in Cardiovascular Medicine, vol.1, issue.1, pp.19-21, 2000. ,
DOI : 10.1186/CVM-1-1-019
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration, Annals of Internal Medicine, vol.134, issue.8 ,
DOI : 10.7326/0003-4819-134-8-200104170-00012